Key result
Novel computational models accurately predict hERG channel blockade with ~0.88 ROC AUC.
Why the study?
Drug-induced QT interval prolongation from hERG channel blockade is a critical adverse effect causing drug withdrawals, making early identification of potential blockers essential to reduce cardiotoxicity-related attrition during drug development.
Effect estimate: ROC AUC 0.88; AAE 0.383 log units
Highly accurate computational classification and regression models utilizing customized atom-type descriptors can robustly predict hERG channel blockade, significantly aiding the early assessment of cardiotoxicity liabilities in drug development.
High Resolution Image Download MS PowerPoint Slide Drug-induced QT interval prolongation, most commonly resulting from the blockade of a voltage-dependent potassium ion channel encoded by the hERG ( human ether-à-go-go–related gene ), has been recognized as a critical side-effect of noncardiovascular therapeutic agents. This adverse effect has led to withdrawal of many drugs from the market. Early identification of potential hERG channel blockers is therefore essential to mitigate cardiotoxicity-related attrition during the later, more resource-intensive stages of drug development. In this paper, we aimed at understanding ligand-channel interactions, including a detailed analysis of the cryo-electron microscopy (cryo-EM) structures of hERG channels and pharmacophore models shared among known hERG blockers. The highly adaptive nature of the hERG ligand-binding site may poses challenges for structure-based approaches, such as molecular docking, yet also offers mechanistic insights into a longstanding question: why does hERG interact with such a wide variety of small-molecule drugs? To complement these structural observations, we summarized the benefits and limitations of both quantitative and qualitative models and their applications across various stages of drug discovery. We developed highly predictive classification and regression models built using customized atom-type descriptors. The regression model, trained on a large and curated data set (∼8,000 compounds), achieved an average absolute error (AAE) of 0.383 log units and root-mean-square error of prediction (RMSEP) of 0.548 log units on the test sets. Meanwhile, the classification model demonstrated strong performance as well, with a receiver operating characteristic (ROC) area under the curve (AUC) of 0.88. Validation on an external set of 1,133 compounds resulted in an AAE of 0.50 log units. Together, these complementary modeling strategies can significantly aid in the early assessment of cardiovascular liabilities associated with hERG channel blockade, thereby supporting safer and more efficient drug development.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied hERG-related cardiotoxicity (n=9,466). Atom-type-based molecular descriptor computational models was evaluated on Model predictive performance (ROC AUC for classification, AAE for regression) (ROC AUC 0.88; AAE 0.383 log units). Computational classification and regression models utilizing customized atom-type descriptors accurately predicted hERG channel blockade, achieving an average ROC AUC of 0.88 and an average absolute error of 0.383 log units.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: